Theranica, a Montclair, N.J.-based migraine-focused digital therapeutics company, raised $45 million in Series C funding, per Fortune’s Term Sheet. New Rhein Healthcare Investors led the round and was joined by investors including aMoon, Lightspeed Venture Partners, LionBird, Takoa Invest, and Corundum Open Innovation.
Related Posts
Overjet Scores $42.5M in B Round
General Catalyst and Insight Partners led the round.
December 21, 2021
California Lawmakers OK Emergency Loans to Failing Hospitals
A report last month paid for by the California Hospital Association warned that 20% of the state’s more than 400 hospitals were at risk of closing.
May 5, 2023
Future Family Lands $25 Million Series B Investment to Expand Fertility Treatment Financing
Munich Re Ventures led the round.
April 5, 2022
Kintsugi Raises $20M for Depression & Anxiety Biomarker Diagnostic
Insight Partners led the round.
March 1, 2022